---
title: "Levothyroxine - Hyperlipidemia"
sidebar: mydoc_sidebar
permalink: db00451-mesh-d006949-1.html
toc: false 
---


Path ID: `DB00451_MESH_D006949_1`
{% include image.html url="images/db00451-mesh-d006949-1.png" file="db00451-mesh-d006949-1.png" alt="db00451-mesh-d006949-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D013974">MESH:D013974 </a> | Levothyroxine | Drug |
| <a href="https://identifiers.org/MESH:D014284">MESH:D014284 </a> | Triiodothyronine | ChemicalSubstance |
| <a href="https://identifiers.org/UniProt:P10827">UniProt:P10827 </a> | Thyroid hormone receptor alpha | Protein |
| <a href="https://identifiers.org/UniProt:P10828">UniProt:P10828 </a> | Thyroid hormone receptor beta | Protein |
| <a href="https://identifiers.org/GO:0002154">GO:0002154 </a> | Thyroid hormone mediated signaling pathway | BiologicalProcess |
| <a href="https://identifiers.org/UniProt:P01130">UniProt:P01130 </a> | Low-density lipoprotein receptor | Protein |
| <a href="https://identifiers.org/MESH:D008078">MESH:D008078 </a> | Cholesterol, LDL | ChemicalSubstance |
| <a href="https://identifiers.org/UniProt:Q6Q788">UniProt:Q6Q788 </a> | Apolipoprotein A-V | Protein |
| <a href="https://identifiers.org/MESH:D014280">MESH:D014280 </a> | Triglycerides | ChemicalSubstance |
| <a href="https://identifiers.org/MESH:D006949">MESH:D006949 </a> | Hyperlipidemia | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Levothyroxine | HAS METABOLITE | Triiodothyronine |
| Triiodothyronine | INCREASES ACTIVITY OF | Thyroid Hormone Receptor Alpha |
| Triiodothyronine | INCREASES ACTIVITY OF | Thyroid Hormone Receptor Beta |
| Thyroid Hormone Receptor Alpha | POSITIVELY REGULATES | Thyroid Hormone Mediated Signaling Pathway |
| Thyroid Hormone Receptor Beta | POSITIVELY REGULATES | Thyroid Hormone Mediated Signaling Pathway |
| Thyroid Hormone Mediated Signaling Pathway | INCREASES ACTIVITY OF | Low-Density Lipoprotein Receptor |
| Low-Density Lipoprotein Receptor | DECREASES ABUNDANCE OF | Cholesterol, Ldl |
| Cholesterol, Ldl | POSITIVELY CORRELATED WITH | Hyperlipidemia |
| Thyroid Hormone Mediated Signaling Pathway | INCREASES ACTIVITY OF | Apolipoprotein A-V |
| Apolipoprotein A-V | DECREASES ABUNDANCE OF | Triglycerides |
| Triglycerides | POSITIVELY CORRELATED WITH | Hyperlipidemia |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00451](https://go.drugbank.com/drugs/DB00451)
  - [https://en.wikipedia.org/wiki/LDL_receptor#Function](https://en.wikipedia.org/wiki/LDL_receptor#Function)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129606/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129606/)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109527/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109527/)
